《Cancer Clinical Pharmacology》是Oxford Univ Pr出版的圖書，作者是Schellens, Jan H. M. (EDT)、McLeod, Howard L. (EDT)、Newell, David R. (EDT)。
and Pralatrexate * A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens * Diagrams of drug structures and pathways for each agent * Offers a comprehensive discussion of clinical pharmacology,...
14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and ItsRole in Detoxification and in Multidrug Resistance of CancerChemotherapy 15 The Role of Traditional Chinese Medicine in ClinicalOncology 16 Effect of Arsenic Trioxide ...
Molecular Medicine; Biochemical Pharmacology; Frontiers in Pharmacology; Molecular Pharmacology; Food and Chemical Toxicology; Investigational New Drugs; BMC Cancer; Toxicology; Acta Pharmacologica Sinica; Basic &Clinical Pharmacology ...
生活質量等）的預測模型包括個體化NSCLC放療相關毒性風險預測模型（Clinical Pharmacology &Therapeutics. 2014），預估早期NSCLC的復發風險（Clinical Pharmacology &Therapeutics，2018），個體化乳腺癌的復發預測模型（Journal of National Cancer...
專著/教材：Pharmacology（主編）、Molecular Determinants of Head and Neck Cancer、Gene Function Analysis、Ribosomes: Structure, Function and Dynamics、有機質譜在生物醫藥中的套用等。榮譽獎項 江蘇省首屆創新爭先獎章、江蘇省傑出青年...
（1）The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology, July ...
1. A phase II trial of Xeloda and oxaliplatin (XELOX) neo- adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis Cancer Chemotherapy Pharmacology. 2014, 73:...
Hao YT, Guo P, Wang FH, Zeng YX, Xu RH#. Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway. Cancer Chemotherapy and Pharmacology. ...
果發表在Nature（Outlook），Gut，JAMA Oncology，Pharmacological Research，Pharmacology & Therapeutics，Oncogene，Cancer Letters，British Journal of Cancer等國際重要期刊上已發表SCI論文150餘篇 。獲國際發明授權專利39項 。長期從事 中藥...
多數發表在腫瘤或藥理專業國際核心刊物如“Cancer Research”、“Clinical Cancer Research”、“Neuro-Oncology”、“Molecular Cancer Therapeutics”、“Molecular Oncology”、“Molecular Pharmacology”等，累計影響因子203.590，單篇影響因子...
